Prioritizing Medical Countermeasures for National Security Act of 2023

1/2
Status In Committee
Sponsor Joni Ernst
Citation 118-S-1122
Actions 2
Introduced Mar 30th, 2023
Cosponsors
2
Last Action Mar 30th, 2023
Policy Area
Introduced Senate Mar 30
Senate
House
President
Enacted

Summary

AI Guide

What this bill does

Loading AI analysis…

Prioritizing Medical Countermeasures for National Security Act of 2023 This bill requires the Administration for Strategic Preparedness and Response (ASPR) to establish a list of categories of drugs that may be necessary to address a public health emergency or threat to the Armed Forces in order to facilitate the development of such drugs. Specifically, ASPR must list categories and classes of drugs that may be necessary to prevent or treat diseases or conditions that are caused by chemical, biological, radiological, or nuclear agents and that have the potential to cause a public health emergency that threatens national security, or that may pose a threat to the Armed Forces. ASPR must share the list with interested parties to incentivize development and speed review of relevant drug applications. The Government Accountability Office must report on the bill's effectiveness in encouraging the development of necessary medical countermeasures.

Actions

2
Senate
INTRODUCED
INTRODUCED
Mar 30, 2023
ON FLOOR
REFERRED TO COMMITTEE
Version
Font size